06 October 2026

Fette Compacting and SOTAX partner to accelerate OSD development

By combining expertise in formulation, tableting and analytical testing, Fette Compacting and SOTAX help pharmaceutical manufacturers accelerate OSD development, reduce complexity and build quality into products from the start.

The development of oral solid dosage (OSD) products depends on the close interaction between formulation, manufacturing processes and product performance. Yet in many development projects, formulation, process development and analytical testing are still handled separately, often resulting in additional coordination efforts, repeated testing and delays during scale-up.

To address these challenges, Fette Compacting and SOTAX have entered into a strategic partnership that brings process expertise and analytical science closer together. The collaboration combines Fette Compacting's knowledge in formulation development, tableting technology, process optimization and scale-up with SOTAX's Pharma Services expertise in analytical development, dissolution testing, content uniformity testing and pharmaceutical quality control.

The partnership is designed to support pharmaceutical manufacturers throughout the entire development journey, from early material characterization and formulation development to commercial production. By integrating analytical considerations into formulation & process development activities from the beginning, product performance and critical quality attributes can be assessed earlier and more effectively, enabling faster and better-informed decisions.

Together, the two companies aim to create a more seamless development cycle in which formulation, process parameters and analytical results continuously inform one another. When changes are made to materials, formulations or manufacturing conditions, their impact on product quality and performance can be evaluated quickly, helping development teams reduce unnecessary iterations and accelerate progress toward robust, scalable processes.

Customers benefit from coordinated expertise across traditional development boundaries while continuing to work with specialized experts in their respective fields. The result is a more integrated approach to OSD development, supporting stronger process understanding, more efficient scale-up and greater confidence in development decisions.

The collaboration builds on a long-standing relationship between the two companies and reflects a shared commitment to supporting pharmaceutical manufacturers with innovative solutions across the product lifecycle. Looking ahead, Fette Compacting and SOTAX plan to further expand joint customer projects and strengthen the connection between process development, analytical technologies and digital data flows, creating an even more consistent foundation for future pharmaceutical development.

Together, Fette Compacting and SOTAX are helping pharmaceutical manufacturers move more efficiently from laboratory development to commercial production, with quality built into every step of the process.